Contact
searchSearch
HMP Global

Conference Coverage

News
Comparing Onset of Action of Therapies in Rheumatoid Arthritis
11/13/2024
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to...
11/13/2024
Rheumatology & Arthritis
Conference Coverage
Treat-to-Target Tapering of TNFi Studied for Noninferiority in PsA, axSpA
01/03/2024
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic...
01/03/2024
Rheumatology & Arthritis
Conference Coverage
Victoria Konzett, MD, on RA Flares Based on SDAI and CDAI
12/27/2023
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Dr Peter Taylor on Effectiveness of Upadacitinib in RA Pain Management
12/26/2023
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Gregory McDermott, MD: Predictors of RA-ILD and Subtypes
12/26/2023
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Breakthrough COVID-19 Infection Among RA Patients After Third Dose
12/26/2023
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
This or That? Rieke Alten, MD, Reviews Treatment Preferences for RA Patients
12/20/2023
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Rheumatoid Arthritis and Long COVID—A Double Whammy
12/20/2023
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Vibeke Strand, MD, on Results of the Phase 3 SELECT-EARLY Trial
12/12/2023
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial...
12/12/2023
Rheumatology & Arthritis
Conference Coverage
JAK Inhibitors for Psoriatic Arthritis? Results of the JAK-pot Study
12/05/2023
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been...
12/05/2023
Rheumatology & Arthritis

Popular Articles

Isabelle Amigues, MD, on the Need for a Switch in Terminology: From CTD-ILD to AI-ILD
Podcasts
Isabelle Amigues, MD, on the Need for a Switch in Terminology: From CTD-ILD to AI-ILD
01/06/2021
In this podcast, Isabelle Amigues, MD, explains the reasoning behind why she and other rheumatologists suggest that practitioners stop using the term “connective tissue disease-associated interstitial lung disease.”
In this podcast, Isabelle Amigues, MD, explains the reasoning behind why she and other rheumatologists suggest that practitioners stop using the term “connective tissue disease-associated interstitial lung disease.”
In this podcast, Isabelle...
01/06/2021
Autoimmune
News
Spondyloarthritis Linked With Higher Disease Activity in Early Crohn Disease
11/09/2020
Crohn disease and spondyloarthritis are known to be associated, but less is known about the mechanism behind this relationship. The authors of a study released during ACR Convergence investigated the factors in this connection.
Crohn disease and spondyloarthritis are known to be associated, but less is known about the mechanism behind this relationship. The authors of a study released during ACR Convergence investigated the factors in this connection.
Crohn disease and...
11/09/2020
Autoimmune
News
New Causal Links Observed Between Drug Use and Subsequent Lupus Diagnosis
09/23/2020
The researchers assessed the association between drug use and subsequent diagnosis of cutaneous lupus erythematosus or systemic lupus erythematosus. Here is what they found about fexofenadine hydrochloride, levothyroxine sodium, and more.
The researchers assessed the association between drug use and subsequent diagnosis of cutaneous lupus erythematosus or systemic lupus erythematosus. Here is what they found about fexofenadine hydrochloride, levothyroxine sodium, and more.
The researchers assessed the...
09/23/2020
Autoimmune
News
Combined Imaging Holds Value for Polymyalgia Rheumatica, Giant Cell Arteritis Diagnosis
08/10/2020
Fluorine‐18‐fluorodeoxyglucose positron emission tomography/computed tomography imaging may be helpful for diagnosing patients with, according to the findings of a recent study.
Fluorine‐18‐fluorodeoxyglucose positron emission tomography/computed tomography imaging may be helpful for diagnosing patients with, according to the findings of a recent study.
Fluorine‐18‐fluorodeoxyglucose...
08/10/2020
Autoimmune
Exclusive Preview: Bioelectronic Medicine for Treatment of Rheumatoid Arthritis
Conference Coverage
Exclusive Preview: Bioelectronic Medicine for Treatment of Rheumatoid Arthritis
07/02/2020
David Chernoff, MD, introduces the concept of neuroimmune control of inflammation and its implications for treating patients with rheumatoid arthritis in this video preview of IAS 2020.
David Chernoff, MD, introduces the concept of neuroimmune control of inflammation and its implications for treating patients with rheumatoid arthritis in this video preview of IAS 2020.
David Chernoff, MD, introduces...
07/02/2020
Autoimmune

Stay In the Know

Autoimmune Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use